Startups
QR Pharma is a specialty pharmaceutical company founded to develop novel treatments for Parkinson's disease (PD) and other neurodegenerative disorders.
Overview
Location
United States, Pennsylvania, Easttown Township
Employees
11-50
Phone
+1 610-727-3913
Total raised
$8.21M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 17, 2012 | Funding round | $110K | |
| Jun 2, 2010 | Seed round | $2.4M |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 28, 2016 | QR Pharma Raises $800,000 of Series A Preferred Stock | Existing investors Robin Hood Ventures and individual angels filled this round. QR Pharma will use the funding to continue to develop its lead compound, Posiphen®, build a pipeline and to support the company through the end of a phase II c... |
| May 27, 2015 | Express Scripts wants cancer drug pricing based on outcomes, U.S. Supreme Court decision could lead to more fraud suits (Morning Read) | LIFE SCIENCE Although patent volume slowed to its lowest level in six years, the number of patents filed in the life sciences industries is on the rise. Last year, patents for pharmaceuticals rose 12 percent and increased 7 percent in biote... |
| May 26, 2015 | QR Pharma Closes $5.7M Series A Financing | QR Pharma, Inc., a Berwyn, Pennsylvania-based biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases, closed a $5.7M Series A financing. The round, which was c... |
| Aug 2, 2013 | Heart disease diagnostic gets $200K to build ER triage tool | QR Pharma The specialty pharmaceutical company is developing three treatments for neurodegenerative diseases. It received $140,000 and previously received $610,000. Its lead compound, Posiphen, is being development to reduce the levels of t... |
| Jan 17, 2012 | QR Pharma Receives $110K Follow-on Investment from BFTP/SEP | QR Pharma, Inc., a Berwyn (Montgomery County), PA-based specialty pharmaceutical company, has received $110k follow-on investment from Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP). Ben Franklin previously investe... |
| Oct 31, 2011 | Serial entrepreneur to receive award | “We treated the patients for two weeks,” said Maccecchini. “We need to raise the money to treat patients for 18 months to show normal cognition. It is a slow, steady decline and we need the time to show the difference.” Having built Symphon... |
| Jun 2, 2010 | QR Pharma Completes $2.4M Seed Financing | QR Pharma, Inc., a Radnor, Pennsylvania-based specialty pharmaceutical company focused on developing novel therapeutics for the treatment of Alzheimer’s disease, raised $500,000 in seed financing. Investors include BioAdvance and undisclose... |
| Express Scripts wants cancer drug pricing based on outcomes, U.S. Supreme Court decision could lead to more fraud suits (Morning Read) | TOP STORIES The U.S. Supreme Court partly reversed and partly affirmed a lower court’s decision not to extend the statute of limitations in fraudulent healthcare lawsuits, sending the case, Kellogg, Brown & Root Services Inc. v. United ... | |
| Serial entrepreneur to receive award | Dr. Maria Maccecchini, the CEO of QR Pharmaceuticals in Berwyn, Pennsylvania, is poised to accept the 2011 Iris Newman award for her work as a serial entrepreneur in biotechnology, a career that has spanned more than 20 years. The award wil... |
Show more
Reviews 0
FAQ about QR Pharma
How much funding has QR Pharma raised?
QR Pharma has raised $8.21M in total across 3 funding rounds.
What funding rounds has QR Pharma raised?
Parsers VC lists 3 funding rounds of QR Pharma, among them a funding round of $110K on Jan 17, 2012 and a seed round of $2.4M on Jun 2, 2010.
What has the press written about QR Pharma?
Parsers VC has collected 11 articles mentioning QR Pharma, among them “QR Pharma Raises $800,000 of Series A Preferred Stock” (Oct 28, 2016) and “Express Scripts wants cancer drug pricing based on outcomes, U.S. Supreme Court decision could lead to more fraud suits (Morning Read)” (May 27, 2015).
Is QR Pharma still active?
QR Pharma is probably closed: its latest activity on Parsers VC dates from Oct 28, 2016.